Cuban Ministry of Public Health ( MINSAP by its Spanish acronym) reported today that a total of 7,446,572 people have already received anti-COVID-19 booster doses in Cuba, with the national vaccines Soberana 02, Soberana Plus and Abdala.

An injectable cephalosporin plant, expected to be completed later this year, will allow the production in Cuba of a group of injectable beta-lactam antibiotics, widely used in intensive therapies, and which are currently imported at high costs.

Cuban President Miguel Diaz-Canel described as a new achievement of Cuban science the production of a new vaccine against the SARS-COV-2 Omicron variant.

Cuba studied a total of 2,388 samples for surveillance, 107 of which were positive. The country has accumulated 14,036,595 samples taken and 1,108,201 positive.

 With a total of 9,978,328 people with the complete anti-COVID-19 scheme, Cuba is making progress in the vaccination of its population, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.

Today concludes a technical advisory visit by Dr. Diana Paez Gutierrez, head of the Nuclear Medicine and Diagnostic Imaging Section of the Division of Human Health, at the International Atomic Energy Agency (IAEA).

In order to provide care to mothers in critical condition -due to complications before, during and after childbirth-, the Gynecobstetric Teaching Hospital "Mariana Grajales" in Villa Clara now has a small Intensive Care Unit.

Cuban President Miguel Dáz-Canel Bermúdez described the development of a Cuban vaccine candidate against COVID-19 Omicron strain as another achievement of Cuban science, spearheaded by the Center for Genetic Engineering and Biotechnology (CIGB), which will proceed to carry out the relevant clinical evaluations, CIGB director Dr. Martha Ayala Ávila reported.

Over 1, 500 Guantanamo dengue fever-suspected cases were assisted in local healthcare centers this week, according to local health authorities.

A total of 39,251,817 anti-COVID-19 doses have been administered in Cuba, with the vaccines developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuba studied a total of 1,815 samples for surveillance, 88 of which were positive. The country accumulates 14,029,469 samples taken and 1,107,888 positive.

The first secretary of the Central Committee of the Cuban communist party and president of the country, Miguel Diaz-Canel, called on the people to participate in the prevention and control of dengue fever.

The Latin American Medical School, to the west of Havana, held on Thursday the 2021-2022 graduation ceremony for 822 new professionals, including 799 graduates who took different medical specialties at Havana’s University of Medical Sciences.

Over the past five years, the incidence of viral hepatitis has decreased in Cuba, with about 70 cases of hepatitis B and 200 of hepatitis C per year, so they are not a health problem and work is being done in line with the initiative of the World Health Organization (WHO) to eliminate them by 2030.